Columbia, MD, United States of America

Dong Seok Kim


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2022-2023

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Dong Seok Kim

Introduction

Dong Seok Kim is an accomplished inventor based in Columbia, MD (US). He has made significant contributions to the field of neuroprotective therapies, holding two patents that focus on innovative methods for delivering neuroprotective polypeptides to the central nervous system.

Latest Patents

His latest patents include methods for delivering a neuroprotective polypeptide to at least a portion of the central nervous system (CNS) of a subject. The disclosed method involves administering a therapeutically effective amount of a neuroprotective polypeptide through a controlled-release formulation or a device that provides sustained release. This formulation includes neuroprotective polypeptides such as GLP-1 and exendin-4, which bind to and activate specific receptors. The controlled-release formulation enhances the delivery of the neuroprotective polypeptide across the blood-brain barrier (BBB), improving treatment outcomes for CNS-related diseases.

Career Highlights

Dong Seok Kim has worked with notable organizations, including the Government of the United States of America as represented by the Secretary of the Department of Health and Human Services and Peptron, Inc. His work has been pivotal in advancing therapeutic strategies for CNS-related conditions.

Collaborations

He has collaborated with esteemed colleagues such as Hee Kyung Kim and Nigel H Greig, contributing to the development of innovative solutions in neuroprotection.

Conclusion

Dong Seok Kim's work exemplifies the intersection of innovation and healthcare, particularly in the realm of neuroprotective therapies. His patents and collaborations highlight his commitment to improving treatment options for patients with CNS-related diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…